SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

The improved market conditions have prompted Dewmar International BMC Inc (OTCMKTS:DEWM) to provide significant updates about its shareholders. As per the reports, the information was shared by the company through a written note on its official website. It stated that the Chief Executive Officer of the company had decided to update all the investors about company’s operations and initiatives in the medical marijuana, as well as Industrial Hemp field.

Insights On The Matter:

Dr. Marco Moran opted to address all the shareholders online rather than publically. He wrote a detailed note and provided updates about Dewmar’s recent initiatives to add value to all of its shareholders. According to him, the company has decided to make public all the details and a huge amount of news in two parts to make sure that shareholders get to know all the initiatives that the company has taken.

Since the last time in November 2014, when Moran addressed the shareholders, the company has come far ahead; hence, sharing of news in one report is quite difficult. The major points covering all the details are industrial market developments, recent marketing activities, and potential opportunities for the company globally. Further insights included-

  • Upcoming various industry events, legislative updates, political involvement,
  • New and upcoming research and development projects of the company,
  • Launch of Kush Cakes Brownies in the near future,
  • Updates about investor relations
  • Developments in the Hemp, Cannabidiol (CBD), Medical Marijuana and the rest of the natural food sector.

The management of Dewmar International hopes that all the interested investors would have a look at the announcements made by the CEO of the company. The company would also announce a few important updates about its expansion in the near future. It requests all the customers to stay patient and connected with the company through all the possible means available in the world.